Albemarle Corp. vs Medtronic PLC — how do they compare? Albemarle Corp. trades at $131.06 (market cap $15.27B), while Medtronic PLC trades at $90.25 (market cap $116.07B). The key difference: Medtronic PLC is far larger — about 7.6× Albemarle Corp.'s market cap, and Medtronic PLC pays the higher dividend (3.18%). Which is the better fit depends on your goals.
| ALB | MDT | |
|---|---|---|
Market Cap | $15.27B | $116.07B |
Sector | Basic Materials | Health |
52-Week High | $215.62 | $105.35 |
52-Week Low | $72.58 | $73.75 |
Enterprise Value | $17.75B | $134.82B |
Dividend Yield | 1.27% | 3.18% |
Trailing returns across standard periods
Latest headlines on both assets
Albemarle is the world's largest lithium producer. Our outlook for robust lithium demand is predicated upon increased demand for electric vehicle batteries. Albemarle produces lithium from its salt brine deposits in Chile and the U.S. and its hard rock joint venture mines in Australia. Albemarle is also a global leader in the production of bromine, used in flame retardants. The company is also a major producer of oil refining catalysts.
Read more on ALB →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →